Company: CERO
Filing Date: 2025-09-22
Form Type: 8-K
Source: 0001213900-25-090107
Chunk: 0

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-09-22
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD Disclosure.

On September 22, 2025, CERo Therapeutics Holdings, Inc., a Delaware
corporation (the “Company”), updated its corporate presentation, which it plans to use in meetings with investors,
analysts and others. The presentation can be found on the Company’s website, w ww. cero. bio. The information
set forth on the Company’s website is not included or incorporated by reference herein. A copy of this corporate presentation is
furnished hereto as Exhibit 99.1.

The information in this Item 7.01 and
Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange
Act, except as expressly set forth by specific reference in such filing.

Item
9.01 Financial Statements and Exhibits.